ITFISA
ADPT icon

Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna’s Adaptive Biotechnologies ADPT Stock Holding History

Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$502K Hold
23,400
– – 0.17% 106
2026
Q1 		$325K Buy
23,400
+6,600
+39% +$105K 0.13% 125
2025
Q4 		$273K Buy
+16,800
New +$274K 0.1% 133

Other funds holding ADPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
GIP
Granite Investment Partners El Segundo, California $1.95B AUM 49.89% 1-Year Est. Return

Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna's ADPT Position: Q2 2026 in Review

Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna held its Adaptive Biotechnologies (ADPT) position steady in Q2 2026 at 23,400 shares worth $502K. The position accounts for 0.17% of the portfolio, ranked #106.

Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna first reported a position in ADPT in Q4 2025 and has held it in 3 quarters since. 182 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna held 23,400 shares of Adaptive Biotechnologies worth $502K as of Q2 2026.
  • Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna left its Adaptive Biotechnologies share count unchanged in Q2 2026.
  • Adaptive Biotechnologies made up 0.17% of Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna's portfolio in Q2 2026, its #106 holding.
  • Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna first reported a position in Adaptive Biotechnologies in Q4 2025 and has held it in 3 quarters since.
  • 182 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna's 13F filing for Q2 2026, filed 21 Jul 2026.